Hanns Lochmüller

Hanns is a neurologist and clinical academic specializing in genetic neuromuscular disorders and rare disease. He holds appointments as Senior Scientist at the CHEO Research Institute and Professor of Neurology at the University of Ottawa Brain and Mind Research Institute and Department of Cellular and Molecular Medicine, and is a practising neurologist at The Ottawa Hospital and Ottawa Centre for Neuromuscular Disease. He holds a Canada Research Chair in Neuromuscular Genomics and Health and a CIHR Foundation Grant for his research program on precision health in neuromuscular disease.

Hanns trained as a neurologist in Munich, Germany and in Montreal, Canada. He leads a research group at CHEO RI where his research interests include molecular therapies of neuromuscular disorders, molecular pathogenesis of muscle and neuromuscular junction disorders, neurogenetics and translational research, and genomic approaches for diagnostics and gene discovery in neuromuscular and rare diseases. In addition to his scientific and clinical research interests, he is internationally active in rare disease science policy and research collaborations.

Hanns’s clinical activities focus on clinical research and care of patients with rare neuromuscular disorders, including congenital myasthenic syndromes (CMS), myotonic dystrophy (DM1), spinal muscular atrophy (SMA), and muscular dystrophy. He has a strong commitment to national and international networking and working with patients and patient organizations, and currently leads the Neuromuscular Disease Network for Canada (NMD4C), a new national networking initiative to improve outcomes in neuromuscular disease across Canada, funded by CIHR and Muscular Dystrophy Canada.

For more details about the lab can be found by clicking this link.